Search | Clinical Trials Finder

Conditions: Pre-Eclampsia
Interventions: L-arginine supplementation in a medical food, Vitamin C and E supplementation in a medical food; Procedure
Lead sponsor: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes; Government
Eligibility: 19 Years to 32 Years · Female only
Enrollment: 585 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Anemia
Interventions: INTERCEPT Blood System for Red Blood Cells, Conventional (Control); Device
Lead sponsor: Cerus Corporation; Industry
Eligibility: 4 Years and older
Enrollment: 692 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 12
States / cities: Phoenix, Arizona • New Haven, Connecticut • Jacksonville, Florida + 8 more

Conditions: Ovarian Cancer, Breast Cancer
Interventions: Questionnaire; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2008
U.S. locations: 4
States / cities: Birmingham, Alabama • Los Angeles, California • New York, New York + 1 more

Conditions: Primary Knee Replacement Surgery
Interventions: Robotic exoskeleton device; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pulmonary Artery Hypertension
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pulmonary Hypertension, Familial Persistent, of the Newborn
Interventions: placebo, iv sildenafil; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 0 Days to 4 Days
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 20
States / cities: Little Rock, Arkansas • Sacramento, California • Washington D.C., District of Columbia + 8 more

Conditions: Colorectal Cancer
Interventions: Cologuard; Other
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 20
States / cities: Glendale, Arizona • Mesa, Arizona • Tempe, Arizona + 17 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Placebo, Linagliptin; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 6,991 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 197
States / cities: Huntsville, Alabama • Scottsboro, Alabama • Tuscumbia, Alabama + 150 more

Conditions: Sleep Apnea, Obstructive, Delirium
Interventions: CPAP; Device
Lead sponsor: Duke University; Other
Eligibility: 50 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hyperlipidemia
Interventions: Bococizumab (PF-04950615; RN316), Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 746 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 108
States / cities: Alexander City, Alabama • Auburn, Alabama • Phoenix, Arizona + 72 more

Conditions: Trichomonas Vaginitis, Chlamydia Trachomatis, Neisseria Gonorrhoeae Infection
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 15 Years and older · Female only
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Physical Disability
Interventions: On the Move exercise - exercise leader, Standard program - exercise leader, On the Move exercise - staff activity personnel, Standard program - staff activity personnel; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 424 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Mood Disorders, Prodromal Symptoms, Bipolar Disorder, Parents, Clinical High Risk
Interventions: cognitive behavioral therapy, mindfulness-based cognitive therapy; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 9 Years to 25 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression, Depressive Disorder, Major
Interventions: No intervention; Other
Lead sponsor: Stanford University; Other
Eligibility: 9 Years to 15 Years · Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2011
U.S. locations: 2
States / cities: Stanford, California

Conditions: Stigma, Social, Help-Seeking Behavior
Interventions: Adjusted Content Intervention, Non-Adjusted Intervention Video; Other
Lead sponsor: Research Foundation for Mental Hygiene, Inc.; Other
Eligibility: 18 Years to 35 Years
Enrollment: 1,402 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Diseases, Cardiovascular Risk Factor, Obesity
Interventions: Mediterranean diet, Olive oil and mixed nuts, American Heart Association; Behavioral · Dietary Supplement
Lead sponsor: Auburn University; Other
Eligibility: 19 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Respiratory Syncytial Virus Infections
Interventions: S-337395, Placebo; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 34
States / cities: Los Angeles, California • Toluca Lake, California • Coral Gables, Florida + 20 more

Conditions: Population at Risk
Interventions: Should I Screen website, Should I Screen print booklet; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 298 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: COVID-19, Post Acute Sequelae of COVID-19, Long COVID, Organ Dysfunction Syndrome, Multiple, Frailty Syndrome
Interventions: Blood and nasal swab sampling; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 7
States / cities: Los Angeles, California • Sylmar, California • Torrance, California + 3 more

Conditions: Colo-rectal Cancer
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 25,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2033
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Arteriosclerosis
Interventions: clopidogrel (SR25990); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 45 Years and older
Enrollment: 15,603 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Asymptomatic Amyloid-positive
Interventions: Atabecestat, 5 mg, Atabecestat, 25 mg, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 557 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 64
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 61 more

Conditions: Prostate Cancer, Magnetic Resonance Imaging, Population at Risk
Interventions: Bi-parametric MRI; Diagnostic Test
Lead sponsor: Northwell Health; Other
Eligibility: 40 Years to 55 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Mucopolysaccharidosis (MPS)
Interventions: Not listed
Lead sponsor: Shire; Industry
Eligibility: Up to 7 Years · Male only
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 7
States / cities: Los Angeles, California • Jacksonville, Florida • Minneapolis, Minnesota + 4 more

Search by objective public record fields.

L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia

INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)

Vascular Subphenotypes of Lung Disease in HIV & COPD

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Effect of CPAP on Postoperative Delirium

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing

On the Move: Optimizing Participation in Group Exercise

MBCT and CBT for Youth at High Risk for Mood and Psychotic Disorders: a Randomized Controlled Trial

Mothers With a History of Depression and Their 10-14 Year Old Daughters

Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2

A Mediterranean Diet Nutrition Education Program for the Reduction of Cardiovascular Disease Risk in the Southeastern U.S.

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Educating QUitline Callers About Lung Cancer Screening

COVID-19 Outcome Prediction Algorithm

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)